OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Advances in genome editing through control of DNA repair pathways
Charles D. Yeh, Chris D. Richardson, Jacob E. Corn
Nature Cell Biology (2019) Vol. 21, Iss. 12, pp. 1468-1478
Closed Access | Times Cited: 343

Showing 1-25 of 343 citing articles:

Genome editing with CRISPR–Cas nucleases, base editors, transposases and prime editors
Andrew V. Anzalone, Luke W. Koblan, David R. Liu
Nature Biotechnology (2020) Vol. 38, Iss. 7, pp. 824-844
Closed Access | Times Cited: 1787

CRISPR technology: A decade of genome editing is only the beginning
Joy Y. Wang, Jennifer A. Doudna
Science (2023) Vol. 379, Iss. 6629
Closed Access | Times Cited: 608

Genome-wide programmable transcriptional memory by CRISPR-based epigenome editing
James K. Nuñez, Chen Jin, Greg C. Pommier, et al.
Cell (2021) Vol. 184, Iss. 9, pp. 2503-2519.e17
Open Access | Times Cited: 514

CRISPR-Based Therapeutic Genome Editing: Strategies and In Vivo Delivery by AAV Vectors
Dan Wang, Feng Zhang, Guangping Gao
Cell (2020) Vol. 181, Iss. 1, pp. 136-150
Open Access | Times Cited: 391

Base editing: advances and therapeutic opportunities
Elizabeth M. Porto, Alexis C. Komor, Ian M. Slaymaker, et al.
Nature Reviews Drug Discovery (2020) Vol. 19, Iss. 12, pp. 839-859
Open Access | Times Cited: 347

PnB Designer: a web application to design prime and base editor guide RNAs for animals and plants
Sebastian M. Siegner, Mehmet E. Karasu, Markus Schröder, et al.
BMC Bioinformatics (2021) Vol. 22, Iss. 1
Open Access | Times Cited: 333

DNA Repair Pathway Choices in CRISPR-Cas9-Mediated Genome Editing
Chaoyou Xue, Eric C. Greene
Trends in Genetics (2021) Vol. 37, Iss. 7, pp. 639-656
Open Access | Times Cited: 258

Polymeric Delivery of Therapeutic Nucleic Acids
Ramya Kumar, Cristiam F. Santa Chalarca, Matthew R. Bockman, et al.
Chemical Reviews (2021) Vol. 121, Iss. 18, pp. 11527-11652
Closed Access | Times Cited: 253

A new era in functional genomics screens
Laralynne Przybyla, Luke A. Gilbert
Nature Reviews Genetics (2021) Vol. 23, Iss. 2, pp. 89-103
Closed Access | Times Cited: 182

Gene Therapy in Cancer Treatment: Why Go Nano?
Catarina Roma‐Rodrigues, Lorenzo Rivas-García, Pedro V. Baptista, et al.
Pharmaceutics (2020) Vol. 12, Iss. 3, pp. 233-233
Open Access | Times Cited: 177

Impact of chromatin context on Cas9-induced DNA double-strand break repair pathway balance
Ruben Schep, Eva K. Brinkman, Christ Leemans, et al.
Molecular Cell (2021) Vol. 81, Iss. 10, pp. 2216-2230.e10
Open Access | Times Cited: 166

CRISPR-based genome editing through the lens of DNA repair
Tarun S. Nambiar, Lou Baudrier, Pierre Billon, et al.
Molecular Cell (2022) Vol. 82, Iss. 2, pp. 348-388
Open Access | Times Cited: 154

Efficient gene editing of human long-term hematopoietic stem cells validated by clonal tracking
Samuele Ferrari, Aurélien Jacob, Stefano Beretta, et al.
Nature Biotechnology (2020) Vol. 38, Iss. 11, pp. 1298-1308
Open Access | Times Cited: 148

Deletion and replacement of long genomic sequences using prime editing
Tingting Jiang, Xiao‐Ou Zhang, Zhiping Weng, et al.
Nature Biotechnology (2021) Vol. 40, Iss. 2, pp. 227-234
Open Access | Times Cited: 145

High-yield genome engineering in primary cells using a hybrid ssDNA repair template and small-molecule cocktails
Brian R. Shy, Vivasvan S. Vykunta, Alvin Ha, et al.
Nature Biotechnology (2022) Vol. 41, Iss. 4, pp. 521-531
Open Access | Times Cited: 142

Past, present, and future of CRISPR genome editing technologies
Martin Pacesa, Oana Pelea, Martin Jínek
Cell (2024) Vol. 187, Iss. 5, pp. 1076-1100
Open Access | Times Cited: 131

Prime editing efficiency and fidelity are enhanced in the absence of mismatch repair
Joana Ferreira da Silva, Gonçalo P. Oliveira, E. A. Arasa-Verge, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 126

Precision genome editing using cytosine and adenine base editors in mammalian cells
Tony P. Huang, Gregory A. Newby, David R. Liu
Nature Protocols (2021) Vol. 16, Iss. 2, pp. 1089-1128
Closed Access | Times Cited: 121

CRISPR/Cas: Advances, Limitations, and Applications for Precision Cancer Research
Yue Yang, Jin Xu, Shuyu Ge, et al.
Frontiers in Medicine (2021) Vol. 8
Open Access | Times Cited: 117

The NIH Somatic Cell Genome Editing program
Krishanu Saha, Erik J. Sontheimer, Philip J. Brooks, et al.
Nature (2021) Vol. 592, Iss. 7853, pp. 195-204
Open Access | Times Cited: 107

Human embryonic genome activation initiates at the one-cell stage
Maki Asami, Brian Lam, Marcella Ma, et al.
Cell stem cell (2021) Vol. 29, Iss. 2, pp. 209-216.e4
Open Access | Times Cited: 104

Assessing and advancing the safety of CRISPR-Cas tools: from DNA to RNA editing
Jianli Tao, Daniel E. Bauer, Roberto Chiarle
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 104

Mitigation of chromosome loss in clinical CRISPR-Cas9-engineered T cells
Connor A. Tsuchida, Nadav Brandes, Raymund Bueno, et al.
Cell (2023) Vol. 186, Iss. 21, pp. 4567-4582.e20
Open Access | Times Cited: 93

Prime editing: advances and therapeutic applications
Zhihan Zhao, Peng Shang, Prarthana Mohanraju, et al.
Trends in biotechnology (2023) Vol. 41, Iss. 8, pp. 1000-1012
Open Access | Times Cited: 90

CRISPR technologies for genome, epigenome and transcriptome editing
Lukas Villiger, Julia Joung, Luke W. Koblan, et al.
Nature Reviews Molecular Cell Biology (2024) Vol. 25, Iss. 6, pp. 464-487
Closed Access | Times Cited: 73

Page 1 - Next Page

Scroll to top